Falchi, L. (2016) “BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA”, Mediterranean Journal of Hematology and Infectious Diseases, 8, p. e2016011. doi: 10.4084/mjhid.2016.011.